Research programme: VAC derived cancer vaccine - Immunomic Therapeutics/Lineage Cell Therapeutics
Latest Information Update: 12 May 2021
At a glance
- Originator Immunomic Therapeutics; Lineage Cell Therapeutics
- Class Antineoplastics; Cancer vaccines; Cell therapies; Immunotherapies
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Glioblastoma